Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesMed BioGene Inc

Med BioGene Inc

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
0.015 CAD -0.01 ( 25.00%)
Last update at 2026-11-03T20:56:00Z
VOLUME
6000
Market Cap
0.35M

Momentum Score

…

Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was engaged in the life science business with a focus on the development and commercialization of genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. The company was formerly known as Med BioGene Inc. and changed its name to Many Bright Ideas Technologies Inc. in June 2022. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.06
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Med BioGene Inc (MBI-H.V) is very limited; the company's corporate filings and exchange profile provide few details about its core operations or assets. Because disclosures are sparse, identifiable long-term growth drivers cannot be determined from available public sources and investors should monitor for material filings, clinical or regulatory milestones, asset acquisitions and financing events.

The primary investment risks are lack of transparent public disclosure, low trading liquidity, potential need for external financing with attendant dilution, and execution and regulatory uncertainty typical of early-stage micro-cap issuers.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.02
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-
Net Debt
-
ROCE
95.21%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -0.06M -0.06M -0.05M -0.06M -0.05M
Net income -0.06M -0.06M -0.05M -0.06M -0.05M
Selling general administrative 0.06M 0.06M 0.05M 0.06M 0.05M
Ebit - -0.06M -0.05M -0.06M -0.05M
Ebitda -0.06M -0.06M -0.05M -0.06M -0.05M
Operating income -0.06M -0.06M -0.05M -0.06M -0.05M
Interest expense - 0.00M 0.00M 0.00M 0.00M
Total revenue 0.00M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 0.06M 0.06M 0.05M 0.06M 0.05M
Net income from continuing ops -0.06M -0.06M -0.05M -0.06M -0.05M
Net income applicable to common shares -0.06M -0.06M -0.05M -0.06M -0.05M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 0.00M 0.01M 0.08M 0.01M 0.00M
Total liab 0.07M 0.09M 0.18M 0.05M 0.14M
Total stockholder equity -0.07M -0.08M -0.10M -0.04M -0.13M
Common stock 9.28M 9.21M 9.13M 9.13M 8.97M
Capital stock 9.28M 9.21M 9.13M 9.13M 8.97M
Retained earnings -14.72M -14.66M -14.60M -14.54M -14.48M
Cash 0.00M 0.01M 0.08M 0.01M 0.00M
Total current liabilities 0.07M 0.09M 0.18M 0.05M 0.14M
Other stockholder equity 5.37M 5.37M 5.37M 5.37M 5.38M
Total current assets 0.00M 0.01M 0.08M 0.01M 0.00M
Net tangible assets - -0.08M -0.10M -0.04M -0.13M
Net receivables - 0.00M 0.00M 0.00M 0.00M
Accounts payable 0.03M 0.03M 0.04M 0.04M 0.13M
Non current assets total 0.00M 0.00M 0.00M 0.00M 0.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Change to liabilities 0.00M -0.01M 0.00M -0.09M 0.05M
Total cash from financing activities -0.00M 0.07M 0.07M 0.16M 0.16M
Change to operating activities 0.06M -0.08M 0.13M 0.00M -0.00M
Net income -0.06M -0.06M -0.05M -0.06M -0.05M
Change in cash -0.01M -0.07M 0.07M 0.01M 0.00M
Begin period cash flow 0.01M 0.08M 0.01M 0.00M 0.00M
End period cash flow 0.00M 0.01M 0.08M 0.01M 0.00M
Total cash from operating activities -0.01M -0.15M 0.07M -0.15M -0.01M
Issuance of capital stock 0.00M 0.07M 0.00M 0.16M -
Change to account receivables -0.00M 0.00M -0.00M -0.00M -0.00M
Other cashflows from financing activities -0.00M -0.00M -0.00M -0.00M -0.00M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.05M -0.09M 0.13M -0.09M 0.05M
Free cash flow -0.01M -0.15M 0.07M -0.15M -0.01M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
MBI-H
Med BioGene Inc		 -0.01
25.00%		 0.01 - - - - -3.03
AVCR
Avricore Health Inc		 -
-%		 0.05 - - 3.16 5.09 41.13
TELO
Telo Genomics Corp		 -0.01
10.00%		 0.04 - - - 8.78 -6.32
ARC
Arian Resources Corp.		 -
-%		 0.01 - - 2.12 - 2.25

Profile*

Med BioGene Inc

Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was engaged in the life science business with a focus on the development and commercialization of genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. The company was formerly known as Med BioGene Inc. and changed its name to Many Bright Ideas Technologies Inc. in June 2022. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

598 East Kent Avenue South, Vancouver, BC, Canada, V5X 4V6

604 732 7332

https://www.medbiogene.com

Name Title Year Born
Dr. Iain Weir-Jones FGS, P.Eng., Ph.D. Chairman & CEO NA
Mr. Ibrahim Ghobrial Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…